Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history.

(Cofotoisme/Getty Images)

New weekly injection offers diabetics alternative to daily insulin shots

 What to know

Novo Nordisk has launched Awiqli, the first weekly insulin injection for Type 2 diabetes. While it reduces daily injections, it poses hypoglycemia risks. Insurance coverage remains uncertain, and experts suggest cautious dosing.

Summary is AI-generated, newsroom-reviewed.

Join the conversation

Have a question? Ask the Post AI to learn more